Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. (FULC) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 133 transactions totaling $116.4M, demonstrating a bearish sentiment with -$16.2M in net insider flow. The most recent transaction on Jan 2, 2026 involved a sale of 15,000 shares valued at $178.1K.
FULC Insider Activity Summary
Who Is Buying FULC Stock?
No significant insider buying has been recorded for FULC in the recent period.
Who Is Selling FULC Stock?
No significant insider selling has been recorded for FULC in the recent period.
Is Fulcrum Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for FULC is bearish with an Insider Alignment Score of 43/100 and a net flow of -$16.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
FULC Frequently Asked Questions
Understanding FULC Insider Activity
Insider trading at Fulcrum Therapeutics, Inc. (FULC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading FULC stock, having executed 133 transactions in the past 90 days. The most active insider is Capital Healthcare Fund Lp Ra (Executive), who has made 5 transactions totaling $59.7M.
Related Tools
Track Fulcrum Therapeutics, Inc. Insider Activity
Get notified when executives and directors at FULC file new Form 4 transactions